Indazole derivatives useful as ERK inhibitors
US8946216B2 · kind B2 · utility
24Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2011 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | Aug 29, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/113
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of the Formula I: Formula I or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2, R3, R4, X, m and n are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.